Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 4 Recruiting 3 Completed 3 Withdrawn 1 Terminated 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 1

Interventions

Gemcitabine 7 Specimen Handling 6 Oxaliplatin 5 Irinotecan 5 S 1 (combination) 4 Magnetic Resonance Spectroscopy 4 Leucovorin 4 Fluorouracil 4 Capecitabine 4 Biopsy 4 Bevacizumab 4 Radiotherapy 3 Nivolumab 3 Immunotherapy 3 Drug Therapy 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 trifluridine tipiracil drug combination 2 titanium silicide 2 spartalizumab 2 lenvatinib 2 aldesleukin 2 Taxes 2 Surgical Procedures, Operative 2 Radiosurgery 2 Photochemotherapy 2 Interleukin-2 2 Endoscopic Mucosal Resection 2 Cyclophosphamide 2 Cisplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × tucatinib × Gastrointestinal × Clear all

NCT05062889 2026-02-03

ERASE-CRC

Gruppo Oncologico del Nord-Ovest

Phase 2 Suspended

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡